Atlas Trials

Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)

Clinical trial NCT07428538 · RECRUITING

Trial details

NCT number
NCT07428538
Sponsor
Bausch Health Americas, Inc.
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis
Start date
2026-01-29
Primary completion
2027-11-01
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.